Haemostatic percutaneous injection therapy for renal trauma guided by contrast-enhanced ultrasonography
10.3760/cma.j.issn.1004-4477.2009.12.013
- VernacularTitle:超声造影引导经皮注射止血剂治疗肾挫裂伤出血
- Author:
Zhiyan LI
;
Jie TANG
;
Faqin Lü
;
Yukun LUO
;
Tengfei YU
;
Qing SONG
;
Ziyu JIAO
- Publication Type:Journal Article
- Keywords:
Ultrasonography;
Microbubbles;
Kidney/injuries;
Hemostasis
- From:
Chinese Journal of Ultrasonography
2009;18(12):1053-1056
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study haemostatic percutaneous injection therapy for the management of vascular damage in patients with renal injuries guided by contrast-enhanced ultrasonography(CEUS).Methods Which of 56 patients with renal trauma were diagnosis by CEUS,37 cases with grades Ⅱ-Ⅳ renal injuries were brought into our study.According to wound degree and accompanying active bleeding,they were divided into experiment group (percutaneous injection hemostatic treatment)and control group(conservative treatment).Results Thirty-seven renal trauma manifest low perfusion in lesions by CEUS,and the contrast agent could be seen overflow to renal pelvi and the location of capsule in 13 patients.The patients were divided into experiment group(17 cases)and control group(20 cases).The color of hematuria of 9 patients in experiment group became gradually light at 30 mins after treatment.and the color of 7 cases become normal,and hematuria of the only one was iterative appear.The color of hematuria of 9 patients in control group became gradually light in 24-72 hours,others' hematuria became gradually light in 5-14 days.The time of color of hematuria become light of the former was shorter than those of the latter(P<0.05).Reexamination by ultrasound and renal function and urine routine at 1,3 and 6 months after treatment,the results of all patients indicated normal.Conclusions Haemostatic percutaneous injection therapy for renal trauma guided by contrast-enhanced ultrasonography has very obvious hemostatic efficacy.Its advantages included may be used for effective,minimally invasive control of renal injuries(grades Ⅱ-Ⅳ),and can be a feasible management of active bleeding at bedside.
